Propranolol therapy for tardive dyskinesia revisited

Movement Disorders

Volumn 27, Issue 13, 2012, Pages 1703-

  Factor, Stewart A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

AGED; CASE REPORT; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RESPIRATORY DYSKINESIA; TARDIVE DYSKINESIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS; PROPRANOLOL;

EID: 84870318173     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25231     Document Type: Letter

References (7)

1. Ondo WG, Hanna PA, Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry 1999; 156: 1279-1281.
2. Wilbur R, Kulik FA. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms. Prog Neuropsychopharmacol 1980; 4: 627-632.
3. Bacher NM, Lewis HA. Low-dose propranolol in tardive dyskinesia. Am J Psychiatry 1980; 137: 495-497.
4. Schrodt GR Jr, Wright JH, Simpson R, Moore DP, Chase S. Treatment of tardive dyskinesia with propranolol. J Clin Psychiatry 1982; 43: 328-331.
5. Perényi A, Farkas A. Propranolol in the treatment of tardive dyskinesia. Biol Psychiatry 1983; 18: 391-394.
6. Pitts FN Jr. Treatment of tardive dyskinesia with propranolol. J Clin Psychiatry 1982; 43: 304.
7. Silver JM, Yudofsky SC, Kogan M, Katz BL. Elevation of thioridazine plasma levels by propranolol. Am J Psychiatry 1986; 143: 1290-1292.